AAPL343.17-4.56 (-1.31%) ▼|ABBV288.70+3.10 (+1.08%) ▲|ABT104.34+0.64 (+0.62%) ▲|ACN250.68+1.31 (+0.52%) ▲|ADBE261.87-1.96 (-0.74%) ▼|AMAT382.31+5.07 (+1.34%) ▲|AMD518.10+1.31 (+0.25%) ▲|AMGN449.29+10.03 (+2.28%) ▲|AMT190.50+1.53 (+0.81%) ▲|AMZN250.30+2.30 (+0.93%) ▲|AVGO326.13+4.45 (+1.38%) ▲|AXP317.16+3.94 (+1.26%) ▲|BA187.98-0.37 (-0.19%) ▼|BAC51.24+0.68 (+1.34%) ▲|BKNG154.60-1.23 (-0.79%) ▼|BLK1,133.45+15.20 (+1.36%) ▲|BMY61.69+0.21 (+0.34%) ▲|BNY147.92+3.28 (+2.26%) ▲|BRK-B545.14+2.95 (+0.54%) ▲|C122.56+1.94 (+1.61%) ▲|CAT685.18-0.19 (-0.03%) ▼|CL94.03-0.02 (-0.02%) ▼|CMCSA22.44-0.26 (-1.12%) ▼|COF204.39+3.05 (+1.51%) ▲|COP150.40-0.41 (-0.27%) ▼|COST1,014.90+11.58 (+1.15%) ▲|CRM248.19-0.39 (-0.15%) ▼|CSCO108.72+2.22 (+2.08%) ▲|CVS94.48+1.01 (+1.08%) ▲|CVX232.24-0.97 (-0.42%) ▼|DE631.72-14.43 (-2.23%) ▼|DHR232.83+2.33 (+1.01%) ▲|DIS112.06-0.46 (-0.41%) ▼|DUK125.19+0.21 (+0.17%) ▲|EMR162.17+0.58 (+0.36%) ▲|FDX303.68+4.96 (+1.66%) ▲|GD355.16+5.80 (+1.66%) ▲|GE288.64+3.00 (+1.05%) ▲|GEV830.21+15.21 (+1.87%) ▲|GILD159.23+3.19 (+2.04%) ▲|GM76.75+0.83 (+1.09%) ▲|GOOG317.09-0.19 (-0.06%) ▼|GOOGL320.15-0.06 (-0.02%) ▼|GS893.84+18.16 (+2.07%) ▲|HD321.62+1.79 (+0.56%) ▲|HON220.34-0.81 (-0.36%) ▼|IBM255.54+1.98 (+0.78%) ▲|INTC87.42+0.46 (+0.53%) ▲|INTU342.94-0.45 (-0.13%) ▼|ISRG458.00+5.71 (+1.26%) ▲|JNJ270.14+6.33 (+2.40%) ▲|JPM336.17+4.59 (+1.38%) ▲|KO92.20-0.51 (-0.55%) ▼|LIN510.11+1.28 (+0.25%) ▲|LLY1,284.44+10.98 (+0.86%) ▲|LMT621.74+17.56 (+2.91%) ▲|LOW200.44+1.76 (+0.88%) ▲|LRCX236.13+6.03 (+2.62%) ▲|MA618.17-5.43 (-0.87%) ▼|MCD252.42+3.96 (+1.59%) ▲|MDLZ63.23-0.58 (-0.90%) ▼|MDT95.57+0.16 (+0.17%) ▲|META636.28-6.34 (-0.99%) ▼|MMM174.40+0.94 (+0.54%) ▲|MO73.81-0.50 (-0.67%) ▼|MRK144.38-0.89 (-0.61%) ▼|MS184.10+4.61 (+2.57%) ▲|MSFT526.66+2.15 (+0.41%) ▲|MU888.06+10.51 (+1.20%) ▲|NEE82.68+0.58 (+0.70%) ▲|NFLX65.29-0.57 (-0.86%) ▼|NKE38.28+0.98 (+2.61%) ▲|NOW157.54-1.42 (-0.89%) ▼|NVDA214.72+3.76 (+1.78%) ▲|ORCL126.40+0.24 (+0.19%) ▲|PEP137.09+1.32 (+0.97%) ▲|PFE30.12+0.09 (+0.28%) ▲|PG160.93-0.09 (-0.06%) ▼|PLTR195.94-0.82 (-0.41%) ▼|PM202.91+3.44 (+1.72%) ▲|QCOM176.91+1.00 (+0.57%) ▲|RTX194.88+3.87 (+2.03%) ▲|SBUX103.05+2.25 (+2.23%) ▲|SCHW90.79+0.21 (+0.23%) ▲|SO92.81-0.08 (-0.09%) ▼|SPG213.24+1.61 (+0.76%) ▲|T21.06+0.13 (+0.60%) ▲|TMO681.35+7.53 (+1.12%) ▲|TMUS144.85-1.69 (-1.15%) ▼|TSLA393.83+21.61 (+5.80%) ▲|TXN285.58+0.89 (+0.31%) ▲|UBER66.80+0.10 (+0.15%) ▲|UNH419.82+1.73 (+0.41%) ▲|UNP294.92+2.05 (+0.70%) ▲|UPS101.05-0.01 (-0.01%) ▼|USB60.20+0.62 (+1.04%) ▲|V405.73-2.19 (-0.54%) ▼|VZ43.53-1.14 (-2.54%) ▼|WFC83.75+1.36 (+1.64%) ▲|WMT121.48+1.59 (+1.33%) ▲|XOM182.82-0.39 (-0.21%) ▼|AAPL343.17-4.56 (-1.31%) ▼|ABBV288.70+3.10 (+1.08%) ▲|ABT104.34+0.64 (+0.62%) ▲|ACN250.68+1.31 (+0.52%) ▲|ADBE261.87-1.96 (-0.74%) ▼|AMAT382.31+5.07 (+1.34%) ▲|AMD518.10+1.31 (+0.25%) ▲|AMGN449.29+10.03 (+2.28%) ▲|AMT190.50+1.53 (+0.81%) ▲|AMZN250.30+2.30 (+0.93%) ▲|AVGO326.13+4.45 (+1.38%) ▲|AXP317.16+3.94 (+1.26%) ▲|BA187.98-0.37 (-0.19%) ▼|BAC51.24+0.68 (+1.34%) ▲|BKNG154.60-1.23 (-0.79%) ▼|BLK1,133.45+15.20 (+1.36%) ▲|BMY61.69+0.21 (+0.34%) ▲|BNY147.92+3.28 (+2.26%) ▲|BRK-B545.14+2.95 (+0.54%) ▲|C122.56+1.94 (+1.61%) ▲|CAT685.18-0.19 (-0.03%) ▼|CL94.03-0.02 (-0.02%) ▼|CMCSA22.44-0.26 (-1.12%) ▼|COF204.39+3.05 (+1.51%) ▲|COP150.40-0.41 (-0.27%) ▼|COST1,014.90+11.58 (+1.15%) ▲|CRM248.19-0.39 (-0.15%) ▼|CSCO108.72+2.22 (+2.08%) ▲|CVS94.48+1.01 (+1.08%) ▲|CVX232.24-0.97 (-0.42%) ▼|DE631.72-14.43 (-2.23%) ▼|DHR232.83+2.33 (+1.01%) ▲|DIS112.06-0.46 (-0.41%) ▼|DUK125.19+0.21 (+0.17%) ▲|EMR162.17+0.58 (+0.36%) ▲|FDX303.68+4.96 (+1.66%) ▲|GD355.16+5.80 (+1.66%) ▲|GE288.64+3.00 (+1.05%) ▲|GEV830.21+15.21 (+1.87%) ▲|GILD159.23+3.19 (+2.04%) ▲|GM76.75+0.83 (+1.09%) ▲|GOOG317.09-0.19 (-0.06%) ▼|GOOGL320.15-0.06 (-0.02%) ▼|GS893.84+18.16 (+2.07%) ▲|HD321.62+1.79 (+0.56%) ▲|HON220.34-0.81 (-0.36%) ▼|IBM255.54+1.98 (+0.78%) ▲|INTC87.42+0.46 (+0.53%) ▲|INTU342.94-0.45 (-0.13%) ▼|ISRG458.00+5.71 (+1.26%) ▲|JNJ270.14+6.33 (+2.40%) ▲|JPM336.17+4.59 (+1.38%) ▲|KO92.20-0.51 (-0.55%) ▼|LIN510.11+1.28 (+0.25%) ▲|LLY1,284.44+10.98 (+0.86%) ▲|LMT621.74+17.56 (+2.91%) ▲|LOW200.44+1.76 (+0.88%) ▲|LRCX236.13+6.03 (+2.62%) ▲|MA618.17-5.43 (-0.87%) ▼|MCD252.42+3.96 (+1.59%) ▲|MDLZ63.23-0.58 (-0.90%) ▼|MDT95.57+0.16 (+0.17%) ▲|META636.28-6.34 (-0.99%) ▼|MMM174.40+0.94 (+0.54%) ▲|MO73.81-0.50 (-0.67%) ▼|MRK144.38-0.89 (-0.61%) ▼|MS184.10+4.61 (+2.57%) ▲|MSFT526.66+2.15 (+0.41%) ▲|MU888.06+10.51 (+1.20%) ▲|NEE82.68+0.58 (+0.70%) ▲|NFLX65.29-0.57 (-0.86%) ▼|NKE38.28+0.98 (+2.61%) ▲|NOW157.54-1.42 (-0.89%) ▼|NVDA214.72+3.76 (+1.78%) ▲|ORCL126.40+0.24 (+0.19%) ▲|PEP137.09+1.32 (+0.97%) ▲|PFE30.12+0.09 (+0.28%) ▲|PG160.93-0.09 (-0.06%) ▼|PLTR195.94-0.82 (-0.41%) ▼|PM202.91+3.44 (+1.72%) ▲|QCOM176.91+1.00 (+0.57%) ▲|RTX194.88+3.87 (+2.03%) ▲|SBUX103.05+2.25 (+2.23%) ▲|SCHW90.79+0.21 (+0.23%) ▲|SO92.81-0.08 (-0.09%) ▼|SPG213.24+1.61 (+0.76%) ▲|T21.06+0.13 (+0.60%) ▲|TMO681.35+7.53 (+1.12%) ▲|TMUS144.85-1.69 (-1.15%) ▼|TSLA393.83+21.61 (+5.80%) ▲|TXN285.58+0.89 (+0.31%) ▲|UBER66.80+0.10 (+0.15%) ▲|UNH419.82+1.73 (+0.41%) ▲|UNP294.92+2.05 (+0.70%) ▲|UPS101.05-0.01 (-0.01%) ▼|USB60.20+0.62 (+1.04%) ▲|V405.73-2.19 (-0.54%) ▼|VZ43.53-1.14 (-2.54%) ▼|WFC83.75+1.36 (+1.64%) ▲|WMT121.48+1.59 (+1.33%) ▲|XOM182.82-0.39 (-0.21%) ▼|
11 C
New York
Monday, October 26, 2026

Tag: counsel

newsFORsourcecompanycontentinformation1releasesmarket

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Sable Offshore Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SOC

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Sable Offshore Corp. (NYSE: SOC): (1) between May 19, 2025 and June 3, 2025, both dates inclusive (the “Class Period”); and/or (2) pursuant and/or traceable to Sable’s May 21, 2025 secondary public offering (the “SPO”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 26, 2025.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RXST

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the “Class Period”, of the important September 22, 2025 lead plaintiff deadline.

TRSG Announcement: If You Have Suffered Losses in Tungray Technologies Inc (NASDAQ: TRSG), You Are Encouraged to Contact The Rosen Law Firm About Your...

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tungray Technologies Inc (NASDAQ: TRSG) resulting from allegations that Tungray Technologies may have issued materially misleading business information to the investing public.

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public.

DLA Piper advises Grupo Cox in US$4.2 billion Iberdrola Mexico acquisition

NEW YORK, Aug. 2, 2025 /PRNewswire/ -- DLA Piper advised Grupo Cox (Cox), a leading Spanish multinational water and energy company, in its acquisition...

DLA Piper advises Grupo Cox in US$4.2 billion Iberdrola Mexico acquisition

NEW YORK, Aug. 1, 2025 /PRNewswire/ -- DLA Piper advised Grupo Cox (Cox), a leading Spanish multinational water and energy company, in its acquisition...

RCKT IMPORTANT DEADLINE: ROSEN, A LEADING NATIONAL FIRM Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important...

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between September 17, 2024 and May 26, 2025, both dates inclusive (the “Class Period”), of the important August 11, 2025 lead plaintiff deadline.

Erayak Power Solution Group Inc. Announces Closing of $7 Million Registered Direct Offering

Wenzhou, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Erayak Power Solution Group Inc. (NASDAQ: RAYA) ("Erayak" or the "Company"), a leading manufacturer, designer, and exporter of high-quality products in the power supply industry, today announced the closing of its previously announced registered direct offering with certain institutional investors for the sale and purchase of an aggregate of 107,692,307 of the Company’s  Class A ordinary shares, par value $0.0001 per share (the “Shares”) (or Class A ordinary share equivalents in lieu thereof) in a registered direct offering at a purchase price of $0.065 per share. The purchase price for the pre-funded warrants was $0.065 to the purchase price for Shares, less the exercise price of $0.0001 per share.

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options

Empro Group Inc. Announces Closing of Remaining Portion of the Underwriter’s Over-Allotment Option in Connection with its Upsized Initial Public Offering

Selangor, Malaysia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Empro Group Inc. (the “Company” or “EMPG”), a rising beauty and personal care brand headquartered in Malaysia, today announced that it closed the sales of an additional 91,250 ordinary shares of the Company, representing the exercise of the remaining portion of the underwriter’s over-allotment option granted in connection with the Company’s initial public offering (the “IPO”, and together with such over-allotment closing, the “Offering”), at the IPO price of $4.00 per share, less underwriting discounts. As a result, the Company has raised gross proceeds of $365,000 in addition to the previously announced IPO gross proceeds of approximately $5,500,000 and the previously announced gross proceeds of $460,000 arising from the partial exercise by the underwriter of its over-allotment option that closed on July 30, 2025, for aggregate gross of proceeds of $6,325,000, before deducting underwriting discounts and other offering expenses.

Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader

Highly Complementary Companies to Advance Therapies to Address Unmet Patient Needs Respective Generics Businesses and Endo's Sterile Injectables Business to be Combined and Spun...

Dr. Shaun Gregory Morgan & Associates Successfully Represented in DIAC Arbitration for $113M Award

New York, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Franklin Morgan & Associates is proud to announce that in a recent ruling, the Dubai International Arbitration Centre (DIAC) has awarded the firm $113 million in a cross-border commercial dispute. The case created a big stir in the legal community not only because of the scope of the dispute, but also for how it positioned Dubai to the world as a high-value destination for international arbitration.

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ANRO

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto’s initial public offering conducted on or about February 2, 2024 (the “IPO”); and/or (ii) securities between February 2, 2024 and October 22, 2024, both dates inclusive (the “Class Period”), of the important September 19, 2025 lead plaintiff deadline.

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Centene Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CNC

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”), of the important September 8, 2025 lead plaintiff deadline.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCounsel

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers